We sort through the booming marijuana industry and separate the hype from reality, to pinpoint the best investment opportunity. Read More

This small marijuana biotech has garnered intense investor interest, with sharp swings up and down. What’s the real story behind CBIS? Read More

E-commerce giant Amazon dominates the retail jungle, but do competitors and bearish economic indicators threaten the stock? Read More

American Green is a marijuana penny stock in the news lately. Is this company poised for explosive growth or will it crash and burn? Read More

Ethereum has richly rewarded early investors but it has been a roller-coaster ride. Does this cryptocurrency still have the Midas touch? Read More

Amazon announced this month that it's pulling the plug on its e-commerce operations in China. Does that make China-based rival Alibaba Group a compelling buy now? Read More

Aphria's revenue is growing, but the cannabis producer also is losing money and it's the target of a savage short-seller report. Is the stock simply too toxic? Read More

Marijuana firm Acreage Holdings seeks the consumer mainstream. Will a merger with rival Canopy Growth boost Acreage's goal? Read More

Cannabis dispensary chain MedMen seeks to become the "Whole Foods of Pot Shops." Will the company succeed or is it stretched too thin? Read More

Cannabis player Cronos Group is flush with cash, after tobacco giant Altria bought a huge stake in the firm. Does Cronos deserve the hype? Read More